🇺🇸 FDA
Pipeline program

ABO-102, ABO-102, ABO-102

ABT-001

Phase 2 small_molecule active

Quick answer

ABO-102, ABO-102, ABO-102 for Mucopolysaccharidosis type IIIA is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Mucopolysaccharidosis type IIIA
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials